Kizoo Technology Capital – pharmaceutical daily

April 7, 2022 Off

Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round

Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform to develop therapeutics that render calcified tissue and organs supple again, has announced the closing of a $10 million funding round led by Kizoo Technology Capital, a early-stage investor in breakthrough rejuvenation technologies. Other investors in the round include Starbloom Capital and SC Launch.

March 17, 2022 Off

Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed to Develop Repairing-Based Approaches to Reversing Aging

By Dino Mustafić

Kizoo portfolio company Revel Pharmaceuticals has raised $8.4M in Seed financing. The oversubscribed round was led by Kizoo Technology Capital and Starbloom Capital with participation from Tubus LLC. The funds will support Revel as it advances its repair-based enzyme therapy pipeline towards the clinic.